International Collaborations

International Collaborations

International Collaborations: Building Bridges of Global Medical Knowledge
International Collaborations: Building Bridges of Global Medical Knowledge
Strategic Vision for International Collaboration
Strategic Vision for International Collaboration
Recognizing the vital importance of clinical synergy in advancing the healthcare sector, the I.D. Stem Cell and Genome Research Institute places a high priority on fostering cross-border international cooperation. The institute strives to establish strategic partnerships with leading global medical and academic institutions to exchange expertise, share knowledge, and execute joint research and training projects. These collaborations aim to elevate medical service standards, provide the latest therapeutic protocols, and contribute to innovating solutions for health challenges on both regional and international levels.
Recognizing the vital importance of clinical synergy in advancing the healthcare sector, the I.D. Stem Cell and Genome Research Institute places a high priority on fostering cross-border international cooperation. The institute strives to establish strategic partnerships with leading global medical and academic institutions to exchange expertise, share knowledge, and execute joint research and training projects. These collaborations aim to elevate medical service standards, provide the latest therapeutic protocols, and contribute to innovating solutions for health challenges on both regional and international levels.
Objectives of Global Partnerships
Objectives of Global Partnerships
The institute works on building an expansive network of relationships with research centers and pioneering companies worldwide to achieve the following:
Knowledge Exchange: Transferring the latest biotechnologies and genetic advancements between international laboratories.
Joint Research Projects: Collaborating on clinical case studies and the development of cellular therapies.
Competency Enhancement: Qualifying medical and research personnel through global training programs.
Network Expansion: Building an integrated ecosystem that serves the medical community and patients worldwide.
The institute works on building an expansive network of relationships with research centers and pioneering companies worldwide to achieve the following:
Knowledge Exchange: Transferring the latest biotechnologies and genetic advancements between international laboratories.
Joint Research Projects: Collaborating on clinical case studies and the development of cellular therapies.
Competency Enhancement: Qualifying medical and research personnel through global training programs.
Network Expansion: Building an integrated ecosystem that serves the medical community and patients worldwide.
Strategic Partners
The strength of the institute is reflected in its alliances with prestigious entities that support its research and educational mission:
The I.D. Institute is the certified academic and clinical partner of the ABRM, an independent international accreditation body that sets rigorous scientific and ethical standards for practicing this specialty globally. This partnership empowers physicians to achieve the "Gold Standard" of professional excellence and ensures their theoretical and practical competency in utilizing advanced biotechnologies.
To ensure physicians keep pace with the latest scientific developments.
For collaboration in fundamental genetic research.
To support advanced training programs and specialized fellowships.
This partnership embodies the collaboration between the 'I.D.' Institute for Stem Cell and Genetic Research and the International Board of Regenerative and Aesthetic Medicine (IBRAM) to enhance academic and clinical quality standards. The agreement aims to accredit joint training programs, provide internationally recognized Continuing Medical Education (CME) programs, and facilitate the exchange of expertise to elevate practitioner competency and advance regenerative medicine research.
This agreement brings together the 'I.D.' Institute, with its advanced research in genetics and regenerative medicine, and the Jakarta Stem Cell Centre, with its leading clinical expertise, to foster collaboration in joint research and medical knowledge exchange. The partnership aims to develop innovative treatment protocols, train medical personnel, and activate a patient exchange and referral system to ensure the highest standards of vital healthcare are delivered.
الشركاء الاستراتيجيون (Our Partners)
تتجسد قوة المعهد في تحالفاته مع هيئات مرموقة تدعم مسيرته في البحث والتعليم:
The I.D. Institute is the certified academic and clinical partner of the ABRM, an independent international accreditation body that sets rigorous scientific and ethical standards for practicing this specialty globally. This partnership empowers physicians to achieve the "Gold Standard" of professional excellence and ensures their theoretical and practical competency in utilizing advanced biotechnologies.
To ensure physicians keep pace with the latest scientific developments.
For collaboration in fundamental genetic research.
To support advanced training programs and specialized fellowships.
This partnership embodies the collaboration between the 'I.D.' Institute for Stem Cell and Genetic Research and the International Board of Regenerative and Aesthetic Medicine (IBRAM) to enhance academic and clinical quality standards. The agreement aims to accredit joint training programs, provide internationally recognized Continuing Medical Education (CME) programs, and facilitate the exchange of expertise to elevate practitioner competency and advance regenerative medicine research.
This agreement brings together the 'I.D.' Institute, with its advanced research in genetics and regenerative medicine, and the Jakarta Stem Cell Centre, with its leading clinical expertise, to foster collaboration in joint research and medical knowledge exchange. The partnership aims to develop innovative treatment protocols, train medical personnel, and activate a patient exchange and referral system to ensure the highest standards of vital healthcare are delivered.
International Agenda and Scientific Participations 2026
International Agenda and Scientific Participations 2026
The I.D. Institute affirms its global presence through a robust agenda of participations in major international conferences, serving as key educational and research milestones within the ABRM program. These participations aim to integrate academic knowledge with field clinical applications:
The I.D. Institute affirms its global presence through a robust agenda of participations in major international conferences, serving as key educational and research milestones within the ABRM program. These participations aim to integrate academic knowledge with field clinical applications:
March 2026 (Recife, Brazil):
March 2026 (Recife, Brazil):
Event: International Conference on the Fundamentals of Regenerative Medicine.
Activities: Conducting intensive practical workshops on Ultrasound imaging and presenting students' preliminary research projects.
April – June 2026 (Specialized Conference Series):
April – June 2026 (Specialized Conference Series):
Topics: Participation in panel discussions on the basic sciences of orthobiologics, such as Platelet-Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC), alongside conferences focused on "Injection Immersion" to enhance clinical outcomes.
July – August 2026 (Biotechnology Applications):
July – August 2026 (Biotechnology Applications):
Activities: Attending international workshops on complementary therapies such as Extracorporeal Shockwave Therapy (ESWT) and Photobiomodulation, while presenting research papers on updates in stem cell use for Orthopedics.
September 2026 (Research Ethics and Regulations Conference):
September 2026 (Research Ethics and Regulations Conference):
Focus: Participation in international seminars regarding research project design and the ethics of regenerative medicine, coinciding with preparations for the ABRM written examination.
October – December 2026 (Specialized Clinical Summits):
October – December 2026 (Specialized Clinical Summits):
Events: Participation in global conferences to discuss the treatment of Osteoarthritis and Tendinopathy, in addition to the "Orthopain" summit to present the latest approved therapeutic protocols.